NYSEMKT: PHGE
Biomx Inc Stock Ownership - Who owns Biomx?

Insider buying vs selling

Have Biomx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James E. FlynnDirector2025-02-27353,249$0.93
$328.87kBuy
James E. FlynnDirector2025-02-27353,249$0.93
$328.87kBuy

1 of 1

PHGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHGE insiders and whales buy or sell their stock.

PHGE Shareholders

What type of owners hold Biomx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Israel Biofund GP Limited Partnership51.91%13,773,653$7.58MInsider
Erez Chimovits17.44%4,626,978$2.54MInsider
Chidozie Ugwumba11.30%2,997,025$1.65MInsider
James E. Flynn9.40%2,494,108$1.37MInsider
Deerfield Management Company LP9.40%2,494,108$1.37MInstitution
Nantahala Capital Management LLC9.40%2,493,309$1.37MInstitution
Takeda Pharmaceutical Co Ltd9.31%2,470,935$1.36MInsider
Jonas Grossman7.84%2,080,217$1.14MInsider
Morgan Stanley6.99%1,854,032$1.02MInstitution
Fibrosis Foundation Cystic6.74%1,787,758$983.27kInsider

1 of 3

PHGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHGE26.02%73.98%Net Buying
CLRB2.59%97.41%Net BuyingNet Buying
MTVA0.81%99.19%Net BuyingNet Buying
INTS4.20%4.44%Net BuyingNet Buying
ADAP6.21%93.79%Net SellingNet Selling

Biomx Stock Ownership FAQ

Who owns Biomx?

Biomx (NYSEMKT: PHGE) is owned by 41.21% institutional shareholders, 117.17% Biomx insiders, and 0.00% retail investors. Orbimed Israel Biofund GP Limited Partnership is the largest individual Biomx shareholder, owning 13.77M shares representing 51.91% of the company. Orbimed Israel Biofund GP Limited Partnership's Biomx shares are currently valued at $7.69M.

If you're new to stock investing, here's how to buy Biomx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.